16:25 EDT Relmada Therapeutics files $250M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RLMD:
- Rising High: SNDL announces successful bid to acquire Indiva
- Rising High: Clearmind granted patent approval for binge behavior treatment
- Rising High: Exclusive talk with psilocybin CPG brand PATOO
- Relmada Therapeutics reports Q2 EPS (59c), consensus (83c)
- Relmada Therapeutics sees cash position of $70.4M sufficient into 2025